![Theodore Schroeder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Theodore Schroeder
Directeur/Membre du Conseil chez
PHATHOM PHARMACEUTICALS, INC.
Fortune : 61 259 $ au 31/07/2026
Profil
Theodore R.
Schroeder was the founder of Mallinckrodt Hospital Products, Inc., founded in 2004, where the titles held included President, Chief Executive Officer & Director from 2004 to 2014.
Mr. Schroeder was the founder of Zavante Therapeutics, Inc., founded in 2015, where the titles held included President, Chief Executive Officer & Director from 2015 to 2018.
Current jobs include Director at Sharp Hospital Foundation and Independent Director at Phathom Pharmaceuticals, Inc. starting in 2025.
Former jobs include Vice Chairman at Antimicrobials Working Group from 2021 to 2023; Chairman at Biocom, Inc. from 2015 to 2017; Senior Director-Marketing Hospital Products at Dura Pharmaceuticals, Inc. in 2000; Director at Nabriva Therapeutics Plc from 2023 to 2025; Independent Director at Collegium Pharmaceutical, Inc. from 2016 to 2021; Director at Hyperion Therapeutics, Inc. from 2014 to 2015; Director at Incline Therapeutics, Inc.; Independent Director at Cidara Therapeutics, Inc. from 2014 to 2026; Independent Director at Trius Therapeutics, Inc. from 2012 to 2013; Independent Director at Otonomy, Inc. from 2015 to 2023; Principal at Bristol Myers Squibb Co.; Senior VP-North American Sales & Marketing at Elan Pharmaceuticals LLC from 2002 to 2004.
Education includes undergraduate studies at Rutgers State University of New Jersey.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/05/2026 | 7 001 ( 0,01 % ) | 61 259 $ | 31/07/2026 |
Postes actifs de Theodore Schroeder
| Sociétés | Poste | Début |
|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 16/04/2025 |
Sharp Hospital Foundation | Directeur/Membre du Conseil | - |
Anciens postes connus de Theodore Schroeder
| Sociétés | Poste | Fin |
|---|---|---|
| CIDARA THERAPEUTICS | Directeur/Membre du Conseil | 07/01/2026 |
| NABRIVA THERAPEUTICS PLC | Directeur Général | 15/01/2023 |
| OTONOMY | Directeur/Membre du Conseil | 15/02/2023 |
Antimicrobials Working Group
 Antimicrobials Working Group Miscellaneous Commercial ServicesCommercial Services Operates as an association of antimicrobials and diagnostics companies | Président | 17/01/2023 |
| COLLEGIUM PHARMACEUTICAL, INC. | Directeur/Membre du Conseil | 21/05/2021 |
Formation de Theodore Schroeder
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
51
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Dura Pharmaceuticals, Inc.
 Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets prescription pharmaceutical products | Health Technology |
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Elan Pharmaceuticals LLC
 Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Incline Therapeutics, Inc.
 Incline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Commercial Services |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Sharp Hospital Foundation | |
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurology diseases | Health Technology |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Zavante Therapeutics, Inc.
 Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
Antimicrobials Working Group
Antimicrobials Working Group Miscellaneous Commercial ServicesCommercial Services Operates as an association of antimicrobials and diagnostics companies | Commercial Services |
Phathom Pharmaceuticals, Inc.
 Phathom Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel treatments for gastrointestinal diseases and disorders | Health Technology |
